- Home
- ADXN vs PAVM Comparison
ADXN vs PAVM Comparison
Compare ADXN & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADXN | PAVM |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | Switzerland | United States |
| Employees | N/A | 107 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 8.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADXN | PAVM |
|---|---|---|
| Price | $6.88 | $10.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 1.2K | ★ 28.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $86.57 | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.29 | $0.21 |
| 52 Week High | $12.05 | $28.44 |
Technical Indicators
Market Signals| Indicator | ADXN | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 52.47 |
| Support Level | $6.84 | $0.38 |
| Resistance Level | $8.74 | $10.98 |
| Average True Range (ATR) | 0.29 | 0.66 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 34.10 | 44.69 |
Price Performance
Historical ComparisonAbout ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.